Abstract
Alzheimer's Disease (AD) is an invalidating neurodegenerative disorders frequently affecting the aging population. In view of the increase of elderlies, not only in western countries, the related growing societal problems urge for identifying clinical biomarkers in view of potential treatments interfering or blocking the disease course. Among the plenty of anatomo-functional in vivo imaging techniques to inspect brain circuits and physiology, the Magnetic Resonance Imaging (MRI), the functional MRI (fMRI), the Electroencephalography (EEG) and Magnetoencephalography (MEG), have been extensively used for the study of AD, with different achievements and limitations. Eventually, the methodologies summoned by brain connectomics further strengthen the expectations in this field, as shown by recent results obtained with [18F]2-fluoro-2-deoxyglucose 18FDG-PET and fMRI in the prediction of the AD in early stages. However, the inherent complexity of the pathophysiology of the AD suggests that only integrative approaches combining different techniques and methodologies of brain scanning could produce significant breakthroughs in the study of AD. This review proposes a formal framework able to combine brain connectomic data from multimodal acquisitions by means of different in vivo neuroimaging techniques, briefly reporting their different advantages and drawbacks. Indeed, a specialized complex multiplex network, where nodes interact in layers linking the same pair of nodes and each layer reflects a distinct type of brain acquisition, can model the plurality of connectomes recommended in this framework.
Keywords: Alzheimer’s Disease, fMRI, MRI, PET, EEG, multiplex networks, brain connectomes, high-resolution multimodal scanner.
Current Alzheimer Research
Title:Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease
Volume: 13 Issue: 5
Author(s): Antonio Giuliano Zippo and Isabella Castiglioni
Affiliation:
Keywords: Alzheimer’s Disease, fMRI, MRI, PET, EEG, multiplex networks, brain connectomes, high-resolution multimodal scanner.
Abstract: Alzheimer's Disease (AD) is an invalidating neurodegenerative disorders frequently affecting the aging population. In view of the increase of elderlies, not only in western countries, the related growing societal problems urge for identifying clinical biomarkers in view of potential treatments interfering or blocking the disease course. Among the plenty of anatomo-functional in vivo imaging techniques to inspect brain circuits and physiology, the Magnetic Resonance Imaging (MRI), the functional MRI (fMRI), the Electroencephalography (EEG) and Magnetoencephalography (MEG), have been extensively used for the study of AD, with different achievements and limitations. Eventually, the methodologies summoned by brain connectomics further strengthen the expectations in this field, as shown by recent results obtained with [18F]2-fluoro-2-deoxyglucose 18FDG-PET and fMRI in the prediction of the AD in early stages. However, the inherent complexity of the pathophysiology of the AD suggests that only integrative approaches combining different techniques and methodologies of brain scanning could produce significant breakthroughs in the study of AD. This review proposes a formal framework able to combine brain connectomic data from multimodal acquisitions by means of different in vivo neuroimaging techniques, briefly reporting their different advantages and drawbacks. Indeed, a specialized complex multiplex network, where nodes interact in layers linking the same pair of nodes and each layer reflects a distinct type of brain acquisition, can model the plurality of connectomes recommended in this framework.
Export Options
About this article
Cite this article as:
Zippo Giuliano Antonio and Castiglioni Isabella, Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/1567205013666151116142451
DOI https://dx.doi.org/10.2174/1567205013666151116142451 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A PPAR-β/δ Agonist is Neuroprotective and Decreases Cognitive Impairment in a Rodent Model of Parkinson’s Disease
Current Neurovascular Research Nonhuman Primate Models of Alzheimer-Like Cerebral Proteopathy
Current Pharmaceutical Design Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling
Current Medicinal Chemistry The Role of Anionic Peptide Fragments in 1N4R Human Tau Protein Aggregation
Protein & Peptide Letters Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry Intracellular Aβ and its Pathological Role in Alzheimer’s Disease: Lessons from Cellular to Animal Models
Current Alzheimer Research Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
CNS & Neurological Disorders - Drug Targets Docking of Natural Products against Neurodegenerative Diseases: General Concepts
Combinatorial Chemistry & High Throughput Screening CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets A Review: Natural Compounds as Anti-Alzheimer´s Disease Agents
Current Nutrition & Food Science Effect of Radio Frequency Waves of Electromagnetic Field on the Tubulin
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets Editorial (Thematic Issue: Neurobiological and Neurocognitive Basis of the Effects of Cannabinoids in Animals and Man: Therapeutic Potential of Cannabinoids in Psychiatry)
Current Pharmaceutical Design